Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Erion

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Biochemistry|July 28, 1987
Chorismate aminations: partial purification of Escherichia coli PABA synthase and mechanistic comparison with anthranilate synthaseC T Walsh, M D Erion, A E Walts, et al.
Biochemistry|October 8, 1997
Purine nucleoside phosphorylase. 2. Catalytic mechanismM D Erion, J D Stoeckler, W C Guida, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Design, synthesis, and structure-activity relationships of the first highly potent, selective, and bioavailable adenosine 5'-monophosphate deaminase inhibitorsS R Kasibhatla, B C Bookser, J R Appleman, et al.
Biochemistry|October 8, 1997
Purine nucleoside phosphorylase. 3. Reversal of purine base specificity by site-directed mutagenesisJ D Stoeckler, A F Poirot, R M Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Purine nucleoside phosphorylase inhibitors: biochemical and pharmacological studies with 9-benzyl-9-deazaguanine and related compoundsL L Bennett, P W Allan, P E Noker, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1993
The pharmacology of CGS 25462: a potent, orally bioavailable, long-acting inhibitor of neutral endopeptidase 24.11A J Trapani, S De Lombaert, M D Erion, et al.
Biochemistry|October 8, 1997
Purine nucleoside phosphorylase. 1. Structure-function studiesM D Erion, K Takabayashi, H B Smith, et al.
Journal of Medicinal Chemistry|August 24, 2000
Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analoguesB G Ugarkar, J M DaRe, J J Kopcho, et al.
Journal of Medicinal Chemistry|August 24, 2000
Adenosine kinase inhibitors. 2. Synthesis, enzyme inhibition, and antiseizure activity of diaryltubercidin analoguesB G Ugarkar, A J Castellino, J M DaRe, et al.
Annals of the New York Academy of Sciences|June 23, 1993
Application of X-ray crystallographic methods in the design of purine nucleoside phosphorylase inhibitorsS E Ealick, Y S Babu, C E Bugg, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Biochemistry|July 28, 1987
Chorismate aminations: partial purification of Escherichia coli PABA synthase and mechanistic comparison with anthranilate synthaseC T Walsh, M D Erion, A E Walts, et al.
Biochemistry|October 8, 1997
Purine nucleoside phosphorylase. 2. Catalytic mechanismM D Erion, J D Stoeckler, W C Guida, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Design, synthesis, and structure-activity relationships of the first highly potent, selective, and bioavailable adenosine 5'-monophosphate deaminase inhibitorsS R Kasibhatla, B C Bookser, J R Appleman, et al.
Biochemistry|October 8, 1997
Purine nucleoside phosphorylase. 3. Reversal of purine base specificity by site-directed mutagenesisJ D Stoeckler, A F Poirot, R M Smith, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Purine nucleoside phosphorylase inhibitors: biochemical and pharmacological studies with 9-benzyl-9-deazaguanine and related compoundsL L Bennett, P W Allan, P E Noker, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1993
The pharmacology of CGS 25462: a potent, orally bioavailable, long-acting inhibitor of neutral endopeptidase 24.11A J Trapani, S De Lombaert, M D Erion, et al.
Biochemistry|October 8, 1997
Purine nucleoside phosphorylase. 1. Structure-function studiesM D Erion, K Takabayashi, H B Smith, et al.
Journal of Medicinal Chemistry|August 24, 2000
Adenosine kinase inhibitors. 1. Synthesis, enzyme inhibition, and antiseizure activity of 5-iodotubercidin analoguesB G Ugarkar, J M DaRe, J J Kopcho, et al.
Journal of Medicinal Chemistry|August 24, 2000
Adenosine kinase inhibitors. 2. Synthesis, enzyme inhibition, and antiseizure activity of diaryltubercidin analoguesB G Ugarkar, A J Castellino, J M DaRe, et al.
Annals of the New York Academy of Sciences|June 23, 1993
Application of X-ray crystallographic methods in the design of purine nucleoside phosphorylase inhibitorsS E Ealick, Y S Babu, C E Bugg, et al.
Pageof 5